PUBLISHER: TechNavio | PRODUCT CODE: 2126182
PUBLISHER: TechNavio | PRODUCT CODE: 2126182
Global Biotech Market 2026-2030
The global biotech market is forecasted to grow by USD 967.1 bn during 2025-2030, accelerating at a CAGR of 13.2% during the forecast period. The report on the global biotech market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise of artificial intelligence in discovery, expansion of advanced bioprocessing infrastructure, rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.6% |
| CAGR | 13.2% |
| Incremental Value | $967.1 bn |
Technavio's global biotech market is segmented as below:
By Product
- Biologics
- Therapeutics
- Diagnostics
- Industrial biotechnology
- Others
By Type
- Red biotechnology
- White biotechnology
- Green biotechnology
- Grey biotechnology
- Others
By Application
- Healthcare
- Bioinformatics
- Agriculture
- Industrial processing
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the advancements in messenger rna platforms as one of the prime reasons driving the global biotech market growth during the next few years. Also, expansion of plant molecular farming and adoption of single-cell diagnostics will lead to sizable demand in the market.
The report on the global biotech market covers the following areas:
- Global biotech market sizing
- Global biotech market forecast
- Global biotech market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biotech market vendors that include Alnylam Pharmaceuticals Inc., Amgen Inc., argenx SE, Be One Medicines AG, Beam Therapeutics Inc., Biogen Inc., BioMarin Pharmaceutical Inc., BioNTech SE, CRISPR Therapeutics AG, Editas Medicine Inc., Exelixis Inc., Gilead Sciences Inc., Incyte Corp., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., Kymera Therapeutics Inc., Legend Biotech Corp., Moderna Inc., Neurocrine Biosciences Inc., Recursion Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Inc., Vervetx Inc.. Also, the global biotech market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Biotech Market 2020 - 2024
- Historic Market Size - Data Table on Global Biotech Market 2020 - 2024 ($ billion)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ billion)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ billion)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ billion)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ billion)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Biotech Market
- 6.2 Impact of geopolitical conflicts on Global Biotech Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Biologics - Market size and forecast 2025-2030
- 8.4 Therapeutics - Market size and forecast 2025-2030
- 8.5 Diagnostics - Market size and forecast 2025-2030
- 8.6 Industrial biotechnology - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Red biotechnology - Market size and forecast 2025-2030
- 9.4 White biotechnology - Market size and forecast 2025-2030
- 9.5 Green biotechnology - Market size and forecast 2025-2030
- 9.6 Grey biotechnology - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Type
- Market opportunity by Type ($ billion)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Healthcare - Market size and forecast 2025-2030
- 10.4 Bioinformatics - Market size and forecast 2025-2030
- 10.5 Agriculture - Market size and forecast 2025-2030
- 10.6 Industrial processing - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rise of artificial intelligence in discovery
- Expansion of advanced bioprocessing infrastructure
- Rising prevalence of chronic diseases
- 13.2 Market challenges
- High capital requirements and financial friction
- Regulatory complexities and compliance hurdles
- Specialized supply chain vulnerabilities
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Advancements in messenger RNA platforms
- Expansion of plant molecular farming
- Adoption of single-cell diagnostics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Alnylam Pharmaceuticals Inc.
- Alnylam Pharmaceuticals Inc. - Overview
- Alnylam Pharmaceuticals Inc. - Product / Service
- Alnylam Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 15.6 argenx SE
- argenx SE - Overview
- argenx SE - Product / Service
- argenx SE - Key offerings
- SWOT
- 15.7 Be One Medicines AG
- Be One Medicines AG - Overview
- Be One Medicines AG - Product / Service
- Be One Medicines AG - Key offerings
- SWOT
- 15.8 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- 15.9 BioMarin Pharmaceutical Inc.
- BioMarin Pharmaceutical Inc. - Overview
- BioMarin Pharmaceutical Inc. - Business segments
- BioMarin Pharmaceutical Inc. - Key offerings
- BioMarin Pharmaceutical Inc. - Segment focus
- SWOT
- 15.10 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
- 15.11 Exelixis Inc.
- Exelixis Inc. - Overview
- Exelixis Inc. - Product / Service
- Exelixis Inc. - Key offerings
- SWOT
- 15.12 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Business segments
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- Gilead Sciences Inc. - Segment focus
- SWOT
- 15.13 Incyte Corp.
- Incyte Corp. - Overview
- Incyte Corp. - Product / Service
- Incyte Corp. - Key news
- Incyte Corp. - Key offerings
- SWOT
- 15.14 Legend Biotech Corp.
- Legend Biotech Corp. - Overview
- Legend Biotech Corp. - Product / Service
- Legend Biotech Corp. - Key offerings
- SWOT
- 15.15 Moderna Inc.
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
- 15.16 Neurocrine Biosciences Inc.
- Neurocrine Biosciences Inc. - Overview
- Neurocrine Biosciences Inc. - Product / Service
- Neurocrine Biosciences Inc. - Key offerings
- SWOT
- 15.17 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key news
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.18 Vertex Pharmaceuticals Inc.
- Vertex Pharmaceuticals Inc. - Overview
- Vertex Pharmaceuticals Inc. - Product / Service
- Vertex Pharmaceuticals Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
